Loading organizations...
Biopôle operates a prominent life sciences campus in Lausanne, Switzerland, serving as a dynamic ecosystem designed to foster innovation and collaboration. The organization provides a comprehensive environment that integrates industry leaders, academic institutions, and emerging companies within the biotech and life sciences sectors. Its core offering facilitates groundbreaking research and development by offering specialized infrastructure, a collaborative community, and strategic support to accelerate the progress of its resident entities.
Established in December 2004, Biopôle SA was founded by the Canton of Vaud and two host cities, evolving from a regional initiative to centralize biomedical research efforts. The initial insight centered on creating a dedicated physical space where life science expertise could converge and flourish. This public authority-led foundation aimed to cultivate a vibrant hub, leveraging the academic strengths of institutions like the University of Lausanne and nurturing a robust life sciences community.
The campus serves a diverse clientele including established pharmaceutical companies, biotech startups, and research groups, all seeking to advance health innovations. Biopôle’s long-term vision is to remain a leading European life sciences hub, continually adapting its support mechanisms to empower the next generation of impact-driven entrepreneurs. It focuses on encouraging ventures with strong scientific merit and significant growth potential, thereby contributing to the broader advancement of the life sciences industry.
Biopole has 2 tracked investments across 2 companies. The latest tracked deal is $580K Seed in PeriVision in July 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 18, 2023 | PeriVision | $580K Seed | — | Walter Inäbnit, Arijana Walcott, Foundation For Technological Innovation, SICTIC |
| Mar 2, 2022 | Testmate Health | $90K Seed | Biopole | — |